Xueling Ge

690 total citations
37 papers, 435 citations indexed

About

Xueling Ge is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Xueling Ge has authored 37 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Oncology and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Xueling Ge's work include Lymphoma Diagnosis and Treatment (8 papers), Peptidase Inhibition and Analysis (7 papers) and Multiple Myeloma Research and Treatments (5 papers). Xueling Ge is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Peptidase Inhibition and Analysis (7 papers) and Multiple Myeloma Research and Treatments (5 papers). Xueling Ge collaborates with scholars based in China, Canada and United States. Xueling Ge's co-authors include Xin Wang, Lili Feng, Xiao Lv, Kang Lu, Yujie Jiang, Na Chen, Peipei Li, Mei Ding, Mei Ding and Xiaosheng Fang and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

Xueling Ge

36 papers receiving 430 citations

Peers

Countries citing papers authored by Xueling Ge

Since Specialization

Citations

This map shows the geographic impact of Xueling Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueling Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueling Ge more than expected).

Fields of papers citing papers by Xueling Ge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueling Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueling Ge. The network helps show where Xueling Ge may publish in the future.

Co-authorship network of co-authors of Xueling Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Xueling Ge. A scholar is included among the top collaborators of Xueling Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueling Ge. Xueling Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impaired stemness in aging periodontal ligament stem cells is mediated by the progerin/endoplasmic reticulum stress/p53 axis 2024 ·Journal of Advanced Research ·(unknown), (unknown), Jinjin Wang, Yang Zhang, (unknown), Xiaoyu Wang, Xueling Ge, Qingyuan Ye, (unknown), Dongdong Fei, Qintao Wang	2
2	Dyslipidemia in the First 100 days and the Association with Acute Graft-versus-host Disease after Allogeneic Stem Cell Transplantation: A Single-center Retrospective Study in China 2023 ·Transplant Immunology ·(unknown), (unknown), (unknown), Xiaosheng Fang, Mei Ding, Kang Lu, Xueling Ge, (unknown), (unknown), Lingyan Zhang, Hongzhi Xu, Xin Wang, Yujie Jiang	1
3	PAX5 aberrant expression incorporated in MIPI-SP risk scoring system exhibits additive value in mantle cell lymphoma 2023 ·Journal of Molecular Medicine ·Xin Zhang, Han Yang, Yu Nie, Yujie Jiang, (unknown), Xueling Ge, Fang Liu, Ya Zhang, Xin Wang	3
4	Characteristics of Molecular Genetic Mutations and Their Correlation with Prognosis in Adolescent and Adult Patients with Acute Lymphoblastic Leukemia 2023 ·Oncology ·(unknown), Xiaoqian Liu, Ying Li, (unknown), Yahan Li, Ran Tan, Yujie Jiang, (unknown), Xueling Ge, Hongzhi Xu, (unknown), Xiaosheng Fang	1
5	Prognosis and complications of patients with primary gastrointestinal diffuse large B‐cell lymphoma: Development and validation of the systemic inflammation response index‐covered score 2023 ·Cancer Medicine ·(unknown), (unknown), Yujie Jiang, Xueling Ge, (unknown), Mei Ding, (unknown), Fang Liu, Xiangxiang Zhou, Xin Wang	7
6	Derivation and validation of a nutrition-covered prognostic scoring system for extranodal NK/T-cell lymphoma 2023 ·Frontiers in Nutrition ·(unknown), (unknown), Xueling Ge, Ying Li, Yiqing Cai, Xiaohong Chen, Shunfeng Hu, Mei Ding, Xiaosheng Fang, Fang Liu, Xiangxiang Zhou, Xin Wang	2
7	Global Burden, Risk Factors, and Trends of Non-Hodgkin Lymphoma in 2020 and Projections to 2040: A Population-Based Study 2022 ·Blood ·(unknown), (unknown), Xiaosheng Fang, Yujie Jiang, Mei Ding, Xueling Ge, (unknown), Kang Lu, Peipei Li, Ying Li, Hongzhi Xu, (unknown), Xiangxiang Zhou, Xin Wang	2
8	Wilms tumor gent 1 (WT1)-specific adoptive immunotherapy in hematologic diseases 2021 ·International Immunopharmacology ·Yujie Jiang, Xiao Lv, Xueling Ge, (unknown), Qian Zhang, Kang Lu, (unknown), (unknown), Lingyan Zhang, Xin Wang	8
9	Pegylated Liposomal Doxorubicin in Vindesine-Based and Bortezomib-Based Regimens for Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study of Efficacy and Safety 2021 ·Frontiers in Oncology ·Yujia Zhai, Dai Yuan, Xueling Ge, Shunfeng Hu, Peipei Li, Xiaosheng Fang, Ying Li, Xiangxiang Zhou, Xin Wang	1
10	Application of high-throughput gene sequencing in lymphoma 2021 ·Experimental and Molecular Pathology ·Xiao Lv, Qian Wang, Xueling Ge, (unknown), Xin Liu	2
11	Refining models of archaic admixture in Eurasia with ArchaicSeeker 2.0 2021 ·Nature Communications ·Kai Yuan, Xumin Ni, Chang Liu, Yuwen Pan, Lian Deng, Rui Zhang, Yang Gao, Xueling Ge, (unknown), Xixian Ma, Haiyi Lou, Taoyang Wu, Shuhua Xu	26
12	Micro-coevolution of host genetics with gut microbiome in three Chinese ethnic groups 2021 ·Journal of genetics and genomics ·Mingyue Cheng, Xueling Ge, Chaofang Zhong, (unknown), Kang Ning, Shuhua Xu	6
13	<p>Expression and Importance of TMED2 in Multiple Myeloma Cells</p> 2020 ·Cancer Management and Research ·Xueling Ge, Wei Jiang, Yujie Jiang, Xiao Lv, Xin Liu, Xin Wang	12
14	Differentially expressed tRFs in CD5 positive relapsed & refractory diffuse large B cell lymphoma and the bioinformatic analysis for their potential clinical use 2019 ·Biology Direct ·(unknown), Ying Li, Xiaosheng Fang, Lingyan Zhang, (unknown), Xueling Ge, Xin Wang, Yujie Jiang	14
15	PGG.SNV: understanding the evolutionary and medical implications of human single nucleotide variations in diverse populations 2019 ·Genome biology ·Chao Zhang, Yang Gao, Zhilin Ning, Yan Lü, Xiaoxi Zhang, Jiaojiao Liu, Bo Xie, Zhe Xue, Xiaoji Wang, Kai Yuan, Xueling Ge, Yuwen Pan, Chang Liu, Lei Tian, Yuchen Wang, Dongsheng Lu, Boon‐Peng Hoh, Shuhua Xu	28
16	A Preliminary Study on Metadherin as a Potential Marker for Progression of Diffuse Large B Cell Lymphoma 2018 ·Genetic Testing and Molecular Biomarkers ·Xueling Ge, (unknown), Xiaosheng Fang, Yujie Jiang, Mei Ding, Xin Liu, Xin Wang	2
17	Interleukin-9 promotes cell survival and drug resistance in diffuse large B-cell lymphoma 2016 ·Journal of Experimental & Clinical Cancer Research ·Xiao Lv, Lili Feng, Xueling Ge, Kang Lu, Xin Wang	40
18	Metadherin contributes to the pathogenesis of chronic lymphocytic leukemia partially through Wnt/β-catenin pathway 2015 ·Medical Oncology ·Peipei Li, Lili Feng, Na Chen, Xueling Ge, Xiao Lv, Kang Lu, Mei Ding, Dai Yuan, Xin Wang	20
19	Metadherin Contributes to the Pathogenesis of Diffuse Large B-cell Lymphoma 2012 ·PLoS ONE ·Xueling Ge, Xiao Lv, Lili Feng, Xiaoqian Liu, (unknown), Na Chen, Xin Wang	28
20	Role of Wnt canonical pathway in hematological malignancies 2010 ·Journal of Hematology & Oncology ·Xueling Ge, Xin Wang	97

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact